Bristol-Myers Squibb Co. v. Teva Pharms. USA, Inc.
By EsqSocial Corporation 23/07/14
Nature of the Case and Issue(s) Presented: BMS owns the ’244 patent, which covers a nucleoside analogue composed of two regions: a carbocyclic ring and a guanine base. Nucleoside analogues are known to mimic the activity of naturally occurring...
By: Robins, Kaplan, Miller & Ciresi L.L.P.